Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
International Agency for Research on Cancer
Arcus Biosciences, Inc.
Atavistik Bio, Inc
AstraZeneca
University of Kansas Medical Center
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Seagen Inc.
Implenomics
Adcentrx Therapeutics
Sensei Biotherapeutics, Inc.
Cancer Research UK
OncoC4, Inc.
Klus Pharma Inc.
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
SOLTI Breast Cancer Research Group
The University of Texas Health Science Center, Houston
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Adlai Nortye Biopharma Co., Ltd.